Clinical Trials Protocol Authoring using LLMs
<|reference_start|>Clinical Trials Protocol Authoring using LLMs: This report embarks on a mission to revolutionize clinical trial protocol development through the integration of advanced AI technologies. With a focus on leveraging the capabilities of generative AI, specifically GPT-4, this initiative aimed to streamline and enhance the efficiency and accuracy of clinical trial protocols. The methodology encompassed a detailed analysis and preparation of comprehensive drug and study level metadata, followed by the deployment of GPT-4 for automated protocol section generation. Results demonstrated a significant improvement in protocol authoring, highlighted by increases in efficiency, accuracy, and the customization of protocols to specific trial requirements. Challenges encountered during model selection and prompt engineering were systematically addressed, leading to refined methodologies that capitalized on the advanced text generation capabilities of GPT-4. This project not only showcases the practical applications and benefits of generative AI in clinical trial design but also sets a foundation for future innovations in the field.<|reference_end|>
@article{maleki2024clinical,
    title={Clinical Trials Protocol Authoring using LLMs},
    author={Morteza Maleki, SeyedAli Ghahari},
    journal={arXiv preprint arXiv:2404.05044},
    year={2024},
    archivePrefix={arXiv},
    eprint={2404.05044},
    primaryClass={cs.CE}
}